Program: Scientific Program
Session: The Immune System in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Diseases, smoldering myeloma, Plasma Cell Disorders, Lymphoid Malignancies
Session: The Immune System in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Diseases, smoldering myeloma, Plasma Cell Disorders, Lymphoid Malignancies
Monday, December 7, 2020, 11:25 AM-11:30 AM
Disclosures: Dhodapkar: Kite: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Lava Therapeutics: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Amgen: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Celgene/BMS: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Janssen: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board; Roche/Genentech: Membership on an entity's Board of Directors or advisory committees, Other: Advisory Board.
<< Previous Presentation
|
Next Presentation